Scarica l'app Stockscreener
81.77
0.53%
0.43
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché EW Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$81.34
Aprire:
$80.75
Volume 24 ore:
3.33M
Relative Volume:
0.82
Capitalizzazione di mercato:
$48.01B
Reddito:
$5.69B
Utile/perdita netta:
$1.41B
Rapporto P/E:
11.77
EPS:
6.95
Flusso di cassa netto:
$577.90M
1 W Prestazione:
+0.62%
1M Prestazione:
+3.08%
6M Prestazione:
+14.17%
1 anno Prestazione:
+16.88%
Intervallo 1D:
$80.12
$82.05
Intervallo di 1 settimana:
$80.02
$82.05
Portata 52W:
$64.00
$83.00
Edwards Lifesciences Corp Stock (EW) Company Profile
Nome
Edwards Lifesciences Corp
Settore
Industria
Telefono
(949) 250-2500
Indirizzo
ONE EDWARDS WAY, IRVINE, CA
Confronta EW con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EW
Edwards Lifesciences Corp
|
81.77 | 47.75B | 5.69B | 1.41B | 577.90M | 6.95 |
|
ABT
Abbott Laboratories
|
131.46 | 230.89B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.66 | 156.32B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
389.94 | 149.64B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
93.33 | 119.05B | 34.20B | 4.69B | 5.30B | 3.63 |
Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-29 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2025-04-24 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-01-30 | Aggiornamento | Stifel | Hold → Buy |
| 2025-01-16 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2024-12-16 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-10-11 | Ripresa | Morgan Stanley | Equal-Weight |
| 2024-09-18 | Downgrade | Jefferies | Buy → Hold |
| 2024-07-31 | Aggiornamento | Daiwa Securities | Neutral → Outperform |
| 2024-07-29 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2024-07-25 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-07-25 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-07-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-07-25 | Downgrade | TD Cowen | Buy → Hold |
| 2024-07-25 | Downgrade | Truist | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2024-05-22 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-05-14 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-03-07 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-02-02 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2023-11-28 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2023-09-26 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-03-08 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-02-06 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-01-31 | Downgrade | Bernstein | Outperform → Underperform |
| 2023-01-30 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-12-06 | Downgrade | Stifel | Buy → Hold |
| 2022-10-28 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-10-26 | Iniziato | Mizuho | Buy |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-29 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-04-13 | Iniziato | Truist | Buy |
| 2022-04-06 | Iniziato | Wolfe Research | Outperform |
| 2022-03-16 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2022-03-02 | Ripresa | BofA Securities | Neutral |
| 2022-02-02 | Aggiornamento | UBS | Neutral → Buy |
| 2022-01-27 | Reiterato | Citigroup | Buy |
| 2022-01-27 | Reiterato | Evercore ISI | Outperform |
| 2022-01-27 | Reiterato | Raymond James | Outperform |
| 2022-01-27 | Reiterato | Stifel | Buy |
| 2022-01-27 | Reiterato | UBS | Neutral |
| 2021-12-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-12-15 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-12-06 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2021-07-30 | Reiterato | Canaccord Genuity | Buy |
| 2021-07-30 | Reiterato | Deutsche Bank | Hold |
| 2021-07-30 | Reiterato | Jefferies | Buy |
| 2021-07-30 | Reiterato | Morgan Stanley | Overweight |
| 2021-07-30 | Reiterato | Oppenheimer | Outperform |
| 2021-07-30 | Reiterato | Stifel | Buy |
| 2021-07-30 | Reiterato | UBS | Neutral |
| 2021-07-30 | Reiterato | Wells Fargo | Equal Weight |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Neutral |
| 2021-04-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-11 | Reiterato | Canaccord Genuity | Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Underperform |
| 2020-04-28 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Neutral |
| 2020-02-06 | Ripresa | BTIG Research | Neutral |
| 2020-01-10 | Iniziato | Oppenheimer | Outperform |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-10-24 | Reiterato | Canaccord Genuity | Buy |
| 2019-09-23 | Iniziato | Piper Jaffray | Overweight |
| 2019-07-24 | Reiterato | BofA/Merrill | Buy |
| 2019-03-18 | Reiterato | Canaccord Genuity | Buy |
| 2019-01-18 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-01-03 | Iniziato | Deutsche Bank | Hold |
| 2018-11-28 | Iniziato | UBS | Neutral |
| 2018-10-16 | Iniziato | Barclays | Underweight |
| 2018-10-02 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2018-10-02 | Downgrade | Guggenheim | Buy → Neutral |
Mostra tutto
Edwards Lifesciences Corp Borsa (EW) Ultime notizie
Published on: 2025-09-03 02:50:15 - Newser
How to read the order book for Edwards Lifesciences CorporationJuly 2025 Opening Moves & Free Weekly Chart Analysis and Trade Guides - Newser
Can Edwards Lifesciences Corporation stock recover from recent declineTrade Entry Summary & Low Volatility Stock Suggestions - Newser
Healthcare Stocks to Watch: argenx, ICON, and Edwards Lifesciences with Long-Term Potential - AInvest
Leerink Partners Lifts Edwards Lifesciences (EW) Price Target Amid Buybacks Focus - Yahoo Finance
Edwards Lifesciences Stock: Is EW Outperforming the Healthcare Sector? - inkl
Is Edwards Lifesciences Corporation stock ready for a breakout2025 Top Decliners & Short-Term Swing Trade Alerts - Newser
Published on: 2025-09-01 12:29:31 - Newser
Using AI based signals to follow Edwards Lifesciences Corporation2025 Year in Review & Expert-Curated Trade Recommendations - Newser
Signal strength of Edwards Lifesciences Corporation stock in tech scannersJuly 2025 Levels & Real-Time Stock Entry Alerts - Newser
What Fibonacci levels say about Edwards Lifesciences Corporation reboundJuly 2025 Sentiment & Weekly Market Pulse Alerts - Newser
Should you wait for a breakout in Edwards Lifesciences CorporationRecession Risk & Risk Controlled Stock Alerts - Newser
Forecasting Edwards Lifesciences Corporation price range with options data2025 Investor Takeaways & Weekly Chart Analysis and Guides - Newser
How institutional ownership impacts Edwards Lifesciences Corporation stockJuly 2025 Drop Watch & Fast Moving Trade Plans - Newser
Edwards Lifesciences Corporation stock trendline breakdown2025 Biggest Moves & Daily Risk Controlled Trade Plans - Newser
Analyzing net buyer seller activity in Edwards Lifesciences CorporationWeekly Profit Analysis & Free Expert Approved Momentum Trade Ideas - Newser
Is it time to cut losses on Edwards Lifesciences CorporationPortfolio Update Summary & AI Forecast for Swing Trade Picks - Newser
Edwards Lifesciences Stock: Is EW Outperforming The Healthcare Sector? - Barchart.com
Edwards Lifesciences celebrates new ESC guidelines - BioWorld MedTech
Edwards Lifesciences Corporation stock daily chart insightsDip Buying & Safe Entry Zone Tips - Newser
Edwards TAVR Gets Expanded ESC Guidelines for Severe AS Patients - Stock Titan
Edwards praises new aortic valve repair guidelines, reports positive Evoque data - MassDevice
Published on: 2025-08-29 06:42:54 - Newser
DBS Bank Adjusts Price Target on Edwards Lifesciences to $81 From $78, Maintains Hold Rating - MarketScreener
Analyzing recovery setups for Edwards Lifesciences Corporation investors2025 Buyback Activity & Weekly Chart Analysis and Guides - Newser
Building trade automation scripts for Edwards Lifesciences CorporationChart Signals & Safe Entry Momentum Tips - Newser
How Edwards Lifesciences Corporation stock reacts to Fed policy changesIndex Update & Weekly High Return Stock Forecasts - Newser
Edwards Lifesciences Corp Azioni (EW) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.89%
1.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):